WayPoint Biomedical Holdings Inc
WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment. It offers a drink spiking test, the Drink Detective, used to detect date rape drugs, including Ketamine, GHB, and Benzodiazapines; and Health Essist tests fo… Read more
WayPoint Biomedical Holdings Inc (WYPH) - Total Liabilities
Latest total liabilities as of June 2006: $835.79K USD
Based on the latest financial reports, WayPoint Biomedical Holdings Inc (WYPH) has total liabilities worth $835.79K USD as of June 2006.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
WayPoint Biomedical Holdings Inc - Total Liabilities Trend (2004–2005)
This chart illustrates how WayPoint Biomedical Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
WayPoint Biomedical Holdings Inc Competitors by Total Liabilities
The table below lists competitors of WayPoint Biomedical Holdings Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Asia Carbon Industries Inc
PINK:ACRB
|
USA | $3.19 Million |
|
American Spectrum Realty Inc
PINK:AQQSQ
|
USA | $354.64 Million |
|
Upper Street Marketing Inc
PINK:UPPR
|
USA | $1.19 Million |
|
Sixty Six Oilfield Services Inc
PINK:SSOF
|
USA | $1.31K |
|
XIWANG SPECIAL STEE (2XI.SG)
STU:2XI
|
Germany | €10.61 Billion |
|
Hypertension Diagnostics Inc
PINK:HDII
|
USA | $122.40K |
|
Alabama Aircraft Industries Inc
PINK:AAIIQ
|
USA | $41.95 Million |
|
Orpheum Property Inc
PINK:PLFF
|
USA | $1.30 Million |
Liability Composition Analysis (2004–2005)
This chart breaks down WayPoint Biomedical Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.06 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -2.49 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.67 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how WayPoint Biomedical Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for WayPoint Biomedical Holdings Inc (2004–2005)
The table below shows the annual total liabilities of WayPoint Biomedical Holdings Inc from 2004 to 2005.
| Year | Total Liabilities | Change |
|---|---|---|
| 2005-12-31 | $484.33K | +194.93% |
| 2004-12-31 | $164.22K | -- |